$STI
Solidion Technology Inc. Stock $sti

$sti Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024067911 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue			$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.733M	$2.533M	$540.0K
YoY Change	614.76%	369.01%	183.35%
% of Gross Profit
Research & Development	$459.8K	$400.7K	$681.6K
YoY Change	-47.27%	-41.22%
% of Gross Profit
Depreciation & Amortization	$51.72K	$102.9K
YoY Change	-13.43%
% of Gross Profit
Operating Expenses	$4.193M	$2.933M	$535.1K
YoY Change	702.81%	448.13%	180.8%
Operating Profit	-$4.193M	-$2.933M	-$1.033M
YoY Change	191.47%	183.97%
Interest Expense	$7.212M	$24.95M	$1.450M
YoY Change	1216.69%	1620.53%	690376.19%
% of Operating Profit
Other Income/Expense, Net	-$2.444M	$24.95M	$1.451M
YoY Change	-546.18%	1619.8%	679.9%
Pretax Income	-$6.637M	$22.02M	$915.7K
YoY Change	-26234.84%	2304.54%	-20216.5%
Income Tax	$0.00	$0.00	$293.5K
% Of Pretax Income		0.0%	32.05%
Net Earnings	-$6.637M	$22.02M	$622.2K
YoY Change	7462.39%	3438.69%	-3008.52%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.07	$0.25	-$0.01
Diluted Earnings Per Share	-$0.07	$0.23	$0.04
COMMON SHARES
Basic Shares Outstanding	92.48M shares	86.90M shares	69.80M shares
Diluted Shares Outstanding		96.16M shares	69.80M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.189M	$256.5K	$0.00
YoY Change	59333.0%		-100.0%
Cash & Equivalents	$1.189M	$256.5K	$6.258K
Short-Term Investments
Other Short-Term Assets	$356.3K	$777.1K	$200.0K
YoY Change	223.91%	288.57%	-27.13%
Inventory	$24.43K	$24.43K
Prepaid Expenses	$163.8K	$267.7K	$152.7K
Receivables	$999.00	$999.00
Other Receivables	$302.5K	$302.5K
Total Short-Term Assets	$2.037M	$1.629M	$158.9K
YoY Change	1729.08%	925.25%	-83.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.142M	$2.194M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$41.70M
YoY Change			-66.94%
Other Assets		$778.2K
YoY Change
Total Long-Term Assets	$4.064M	$4.910M	$41.75M
YoY Change	-90.44%	-88.24%	-66.94%
TOTAL ASSETS
Total Short-Term Assets	$2.037M	$1.629M	$158.9K
Total Long-Term Assets	$4.064M	$4.910M	$41.75M
Total Assets	$6.101M	$6.540M	$41.91M
YoY Change	-85.68%	-84.39%	-67.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.072M	$3.402M	$1.200M
YoY Change	64.72%	183.49%	741.28%
Accrued Expenses	$890.4K	$890.4K	$0.00
YoY Change	0.04%		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.481M	$3.386M	$1.300M
YoY Change	33.16%	160.48%	937.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.89M	$24.70M	$3.497M
YoY Change	481.22%	606.43%	1180.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.89M	$24.70M	$3.497M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$24.89M	$24.70M	$7.819M
YoY Change	189.24%	215.9%	70.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$104.3M	-$97.70M	-$7.606M
YoY Change	1134.59%	1184.57%	127.07%
Common Stock	$11.73K	$8.709K	$12.00
YoY Change	97675.0%	72475.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$18.79M	-$18.16M	-$7.605M
YoY Change
Total Liabilities & Shareholders Equity	$6.101M	$6.540M	$41.91M
YoY Change	-85.68%	-84.39%	-67.06%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$6.637M	$22.02M	$622.2K
YoY Change	7462.39%	3438.69%	-3008.52%
Depreciation, Depletion And Amortization	$51.72K	$102.9K
YoY Change	-13.43%
Cash From Operating Activities	-$2.136M	-$1.501M	-$1.050M
YoY Change	274.44%	42.92%	73.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$33.10K	-$66.48K	$89.87M
YoY Change	-83.4%	-100.07%
Cash From Investing Activities	-$33.10K	-$66.48K	$89.87M
YoY Change	-83.4%	-100.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.101M	50.00	-88.91M
YoY Change	305.37%	-100.0%
NET CHANGE
Cash From Operating Activities	-2.136M	-1.501M	-1.050M
Cash From Investing Activities	-33.10K	-66.48K	89.87M
Cash From Financing Activities	3.101M	50.00	-88.91M
Net Change In Cash	932.2K	-1.567M	-90.00K
YoY Change	-19519.79%	1641.21%	-85.13%
FREE CASH FLOW
Cash From Operating Activities	-$2.136M	-$1.501M	-$1.050M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41323
	dei	Entity Registrant Name EntityRegistrantName	SOLIDION TECHNOLOGY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1993879
	dei	Entity Address Address Line1 EntityAddressAddressLine1	13355 Noel Rd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
	dei	City Area Code CityAreaCode	(972)
	dei	Local Phone Number LocalPhoneNumber	918-5120
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	STI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	92478443	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	256504	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	780	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	999	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2164	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	302500	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	187500	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	24430	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22730	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	267717	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44892	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	777135	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1629285	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	258066	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2193641	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2319152	usd
CY2024Q2	sti	Patents Net Of Amortization PatentsNetOfAmortization	1938690	usd
CY2023Q4	sti	Patents Net Of Amortization PatentsNetOfAmortization	1852649	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	778167	usd
CY2024Q2	us-gaap	Assets Assets	6539783	usd
CY2023Q4	us-gaap	Assets Assets	4429867	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3401885	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	144923	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	89267	usd
CY2024Q2	sti	Excise Tax Payable ExciseTaxPayable	890385	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	16844750	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	527500	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2858769	usd
CY2024Q2	us-gaap	Liabilities Liabilities	24700429	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1017408	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87100341	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87100341	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69800000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69800000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	8709	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6980	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	79610239	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28850985	usd
CY2024Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	80241	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97699353	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25445506	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-18160646	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3412459	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6539783	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4429867	usd
	us-gaap	Revenues Revenues	300	usd
	us-gaap	Gross Profit GrossProfit	300	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	400658	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	681646	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1129772	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1442131	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2532651	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	351330	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5562873	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1332962	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2933309	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1032976	usd
	us-gaap	Operating Expenses OperatingExpenses	6692645	usd
	us-gaap	Operating Expenses OperatingExpenses	2775093	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2933309	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1032976	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6692645	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2774793	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-24966700	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16784200	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	17820998	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	171	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	482	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	19184	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	22923	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4038	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	391	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4037	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	666	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	24951725	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	391	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1055202	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	666	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	22018416	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1032585	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7747847	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2774127	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86913581	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69800000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82556000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69800000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96159497	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69800000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82556000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69800000	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3412459	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3412459	usd
CY2024Q1	sti	Adjustmentsto Additional Paidin Capital Contributions From Related Party AdjustmentstoAdditionalPaidinCapitalContributionsFromRelatedParty	487273	usd
CY2024Q1	sti	Stock Issued During Period Value Issuance Of Common Stock Upon Consummation Of The Merger StockIssuedDuringPeriodValueIssuanceOfCommonStockUponConsummationOfTheMerger	27887919	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3175000	usd
CY2024Q1	sti	Stock Issued During Period Value Stock Subscription Receivable StockIssuedDuringPeriodValueStockSubscriptionReceivable	-80241	usd
CY2024Q1	sti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	8931997	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	262064	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1359000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-29766263	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-40630758	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	34	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	451662	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	22018416	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-18160646	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5983426	usd
CY2023Q1	sti	Adjustmentsto Additional Paidin Capital Contributions And Net Transfers With Related Parties AdjustmentstoAdditionalPaidinCapitalContributionsAndNetTransfersWithRelatedParties	442368	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1741542	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4684252	usd
CY2023Q2	sti	Adjustmentsto Additional Paidin Capital Contributions And Net Transfers With Related Parties AdjustmentstoAdditionalPaidinCapitalContributionsAndNetTransfersWithRelatedParties	185865	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1032585	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3837532	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7747847	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2774127	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	197303	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	182179	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1810662	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16784200	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	17820998	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1164	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-40	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	115000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1700	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	57418	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	11700	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	777135	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	778167	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2889968	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9135	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	444076	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3541372	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2150397	usd
	us-gaap	Payments For Software PaymentsForSoftware	157834	usd
	us-gaap	Payments For Software PaymentsForSoftware	62235	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-157834	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62235	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	487273	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1592095	usd
	sti	Cash Received From Nubi Trust CashReceivedFromNUBITrust	25160047	usd
	sti	Discount Payment Related To Non Redemption Agreement DiscountPaymentRelatedToNonRedemptionAgreement	13937997	usd
	sti	Payment For Reimbursement Of Consideration Shares Related To The Forward Purchase Agreement PaymentForReimbursementOfConsiderationSharesRelatedToTheForwardPurchaseAgreement	2193800	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	80241	usd
	sti	Business Combination BusinessCombination	8948009	usd
	sti	Inflow From Merger InflowFromMerger	17555	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	527500	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	670000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	424277	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3850000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	34	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	-262064	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	911091	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3954930	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1592095	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	255724	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-620537	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	780	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	621575	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	256504	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1038	usd
	us-gaap	Interest Paid Net InterestPaidNet	89012	usd
	us-gaap	Stock Issued1 StockIssued1	1216	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	22500000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-7747847	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16784200	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	17820998	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3541372	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	256504	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5324624	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4068302	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2023Q4	us-gaap	Other Receivables OtherReceivables	187500	usd
	sti	Percentage Of Additional Trust Funding Requirement PercentageOfAdditionalTrustFundingRequirement	0.50	pure
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	68416	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	125510	usd
	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	64515	usd
	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	156871	usd
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1081011	usd
	sti	Shares Unissued SharesUnissued	857680	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	34495	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	71793	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11992	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25308	usd
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9500000	shares
CY2024Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9500000	shares
	sti	Percentage Of Number Of Stocks Of Common Stock Outstanding PercentageOfNumberOfStocksOfCommonStockOutstanding	0.05	pure
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.</span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	777135	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	778167	usd
	sti	Net Proceeds From Transaction Cost NetProceedsFromTransactionCost	17555	usd
	sti	Earnout Shares EarnoutShares	0	shares
CY2024Q2	sti	Patents Net Accumulated Amortization PatentsNetAccumulatedAmortization	1938690	usd
CY2023Q4	sti	Patents Net Accumulated Amortization PatentsNetAccumulatedAmortization	1852649	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	34057	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	21268	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	487273	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1592095	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	187500	usd
CY2023	sti	Additional Trust Funding Requirement Percentage AdditionalTrustFundingRequirementPercentage	0.50	pure
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	76521	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	13000	usd
CY2024Q2	us-gaap	Payments For Fees PaymentsForFees	669985	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	906000	usd
	sti	Holdback Shares HoldbackShares	200000	shares
	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	1950000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	906000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	200000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69800000	shares
CY2024Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3850000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	522867	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	260803	usd
	sti	Prefund Purchase Price PrefundPurchasePrice	0.0001
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Each Unit consists of (i) one share of Solidion Common Stock, (ii) two Series A warrants (“Series A Warrants”) each to purchase one share of Common Stock, and (iii) one Series B warrant (“Series B Warrants”) to purchase such number of shares of Common Stock as determined on the reset date (as defined in the Subscription Agreement), and in accordance with the terms therein.
CY2024Q2	sti	Redeemed Common Stock Percentage RedeemedCommonStockPercentage	1	pure
	sti	Consideration Receivable Percentage ConsiderationReceivablePercentage	0.70	pure
	sti	Equity Proceeds Percentage EquityProceedsPercentage	0.60	pure
CY2024Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	18
	sti	Market Value And New Issue Price Per Share Percentage MarketValueAndNewIssuePricePerSharePercentage	1.80	pure
CY2024Q2	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	9141900	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	710050	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	199943	shares
CY2024Q1	sti	Cash Payment CashPayment	7352	shares
CY2024Q1	sti	Trust Account TrustAccount	80241	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	5838537	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	8038537	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	9543002	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	8996779	shares
CY2024Q2	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	245051	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	5403534	usd
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	5158483	usd
CY2024Q2	sti	Value Of Weighted Average Price ValueOfWeightedAveragePrice	0.4347
	sti	Warrants Reset Per Share WarrantsResetPerShare	0.3478
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	199943	shares
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	527500	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	527500	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	2858769	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1359000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P6Y
CY2024Q2	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	4800000	usd
CY2024Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	452000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	452000	usd
	sti	Percentage Of Cash Bonus PercentageOfCashBonus	0.025	pure
	us-gaap	Officers Compensation OfficersCompensation	20000000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	8996779	shares
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	216967	usd
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	4815800	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.046	pure
CY2024Q2	us-gaap	Share Price SharePrice	0.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	9543002	shares
CY2024Q2	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	245051	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	5403534	usd
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	5158483	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	17820998	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	sti	Excise Tax Payable ExciseTaxPayable		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2023Q2	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2024Q2	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating		usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating		usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	sti	Cash Received From Nubi Trust CashReceivedFromNUBITrust		usd
	sti	Discount Payment Related To Non Redemption Agreement DiscountPaymentRelatedToNonRedemptionAgreement		usd
	sti	Payment For Reimbursement Of Consideration Shares Related To The Forward Purchase Agreement PaymentForReimbursementOfConsiderationSharesRelatedToTheForwardPurchaseAgreement		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	sti	Business Combination BusinessCombination		usd
	sti	Inflow From Merger InflowFromMerger		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001881551

Files In Submission

Name	View Source	Status
0001213900-24-067911-index-headers.html	Edgar Link	pending
0001213900-24-067911-index.html	Edgar Link	pending
0001213900-24-067911.txt	Edgar Link	pending
0001213900-24-067911-xbrl.zip	Edgar Link	pending
ea0209847-10q_solidion.htm	Edgar Link	pending
ea020984701ex31-1_solidion.htm	Edgar Link	pending
ea020984701ex31-2_solidion.htm	Edgar Link	pending
ea020984701ex32-1_solidion.htm	Edgar Link	pending
ea020984701ex32-2_solidion.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
ea0209847-10q_solidion_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sti-20240630.xsd	Edgar Link	pending
sti-20240630_cal.xml	Edgar Link	unprocessable
sti-20240630_def.xml	Edgar Link	unprocessable
sti-20240630_lab.xml	Edgar Link	unprocessable
sti-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STI
Solidion Technology Inc. Stock $sti

2024 Q3 Form 10-Q Financial Statement

#000121390024067911 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STI Solidion Technology Inc. Stock $sti

2024 Q3 Form 10-Q Financial Statement

#000121390024067911 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STI
Solidion Technology Inc. Stock $sti